These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35908738)

  • 1. Type 2 biologics reduce cumulative steroid exposure in aspirin-exacerbated respiratory disease.
    Ghiasi Y; Wangberg H; Bagsic SRS; White A
    Ann Allergy Asthma Immunol; 2022 Nov; 129(5):642-643. PubMed ID: 35908738
    [No Abstract]   [Full Text] [Related]  

  • 2. Dupilumab as an adjunct to surgery in patients with aspirin-exacerbated respiratory disease.
    Patel P; Bensko JC; Bhattacharyya N; Laidlaw TM; Buchheit KM
    Ann Allergy Asthma Immunol; 2022 Mar; 128(3):326-328. PubMed ID: 34863953
    [No Abstract]   [Full Text] [Related]  

  • 3. Pediatric-onset aspirin-exacerbated respiratory disease: Clinical characteristics, prevalence, and response to dupilumab.
    Bensko JC; McGill A; Palumbo M; Cahill KN; Laidlaw TM
    J Allergy Clin Immunol Pract; 2022 Sep; 10(9):2466-2468. PubMed ID: 35643277
    [No Abstract]   [Full Text] [Related]  

  • 4. Should Biologics Be Used Before Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease?
    Laidlaw TM; White AA
    J Allergy Clin Immunol Pract; 2024 Jan; 12(1):79-84. PubMed ID: 37778627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of aspirin exacerbated respiratory disease patients treated with aspirin desensitization and biologics.
    D'Souza GE; Nwagu U; Barton B; Unsal AA; Rabinowitz MR; Rosen MR; Nyquist GG; Cohn J; Most J; Toskala EM
    Int Forum Allergy Rhinol; 2022 Mar; 12(3):306-309. PubMed ID: 34719120
    [No Abstract]   [Full Text] [Related]  

  • 6. Controversies in Allergy: Aspirin Desensitization or Biologics for Aspirin-Exacerbated Respiratory Disease-How to Choose.
    Laidlaw TM; Chu DK; Stevens WW; White AA
    J Allergy Clin Immunol Pract; 2022 Jun; 10(6):1462-1467. PubMed ID: 34999274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. If aspirin-exacerbated respiratory disease treatment is a jigsaw puzzle, where do the aspirin and biologic pieces go?
    White AA
    Ann Allergy Asthma Immunol; 2022 May; 128(5):484-485. PubMed ID: 35489798
    [No Abstract]   [Full Text] [Related]  

  • 8. Dysbiosis in aspirin-exacerbated respiratory disease.
    Cook KA; Domissy A; Simon RA; White AA; Modena BD
    Int Forum Allergy Rhinol; 2021 Jul; 11(7):1116-1120. PubMed ID: 33438331
    [No Abstract]   [Full Text] [Related]  

  • 9. Utility of nasal mucus inflammatory profile as a biomarker of nasal polyp regrowth in aspirin-exacerbated respiratory disease.
    Corey KB; Turner JH; Chowdhury NI; Chandra RK; Li P; Wu P; Cahill KN
    J Allergy Clin Immunol Pract; 2022 Jun; 10(6):1644-1645.e1. PubMed ID: 35398556
    [No Abstract]   [Full Text] [Related]  

  • 10. Aspirin-Exacerbated Respiratory Disease.
    White AA; Stevenson DD
    N Engl J Med; 2018 Sep; 379(11):1060-1070. PubMed ID: 30207919
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19 in a series of patients with aspirin-exacerbated respiratory disease.
    White AA; Cahill KN; Jerschow E; Kuruvilla M; Sehanobish E; Bensko J; Laidlaw TM; Levy JM
    J Allergy Clin Immunol Pract; 2021 Jul; 9(7):2900-2903. PubMed ID: 33965591
    [No Abstract]   [Full Text] [Related]  

  • 12. Aspirin-exacerbated respiratory disease: not always "adult-onset".
    Tuttle KL; Schneider TR; Henrickson SE; Morris D; Abonia JP; Spergel JM; Laidlaw TM
    J Allergy Clin Immunol Pract; 2016; 4(4):756-8. PubMed ID: 27393784
    [No Abstract]   [Full Text] [Related]  

  • 13. Current complications and treatment of aspirin-exacerbated respiratory disease.
    Cook KA; Stevenson DD
    Expert Rev Respir Med; 2016 Dec; 10(12):1305-1316. PubMed ID: 27817219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidisciplinary single-center outcomes compared to two-center outcomes for the treatment of aspirin exacerbated respiratory disease.
    Bosso JV; Tripathi SH; Kennedy DW; Kohanski MA; Cohen NA; Palmer JN; Adappa ND
    J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2498-2500. PubMed ID: 33548515
    [No Abstract]   [Full Text] [Related]  

  • 15. The Effect of Antileukotrienes on the Results of Postoperative Treatment of Paranasal Sinuses in Patients with Non-Steroidal Anti-Inflammatory Drug-Exacerbated Respiratory Disease.
    Stryjewska-Makuch G; Humeniuk-Arasiewicz M; Jura-Szołtys E; Glück J
    Int Arch Allergy Immunol; 2019; 179(4):281-289. PubMed ID: 31091524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dupilumab-associated arthralgia in patients with aspirin-exacerbated respiratory disease.
    Miss Ozuna L; Ryan T; Bensko JC; Laidlaw TM; Buchheit KM
    Ann Allergy Asthma Immunol; 2022 Apr; 128(4):469-472. PubMed ID: 35124224
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical evaluation and diagnosis of aspirin-exacerbated respiratory disease.
    Haque R; White AA; Jackson DJ; Hopkins C
    J Allergy Clin Immunol; 2021 Aug; 148(2):283-291. PubMed ID: 34364538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukotriene-Associated Rash in Aspirin-Exacerbated Respiratory Disease.
    Laidlaw TM; Gakpo DH; Bensko JC; Buchheit K
    J Allergy Clin Immunol Pract; 2020 Oct; 8(9):3170-3171. PubMed ID: 32739465
    [No Abstract]   [Full Text] [Related]  

  • 19. Aspirin-exacerbated respiratory disease (AERD): Current understanding of AERD.
    Taniguchi M; Mitsui C; Hayashi H; Ono E; Kajiwara K; Mita H; Watai K; Kamide Y; Fukutomi Y; Sekiya K; Higashi N
    Allergol Int; 2019 Jul; 68(3):289-295. PubMed ID: 31235242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of omalizumab on outcomes in patients with aspirin-exacerbated respiratory disease.
    Jean T; Eng V; Sheikh J; Kaplan MS; Goldberg B; Jau Yang S; Samant S
    Allergy Asthma Proc; 2019 Sep; 40(5):316-320. PubMed ID: 31514790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.